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Abstract
Background: Clenbuterol, a beta-agonist, can dramatically reduce pig adipose accumulation at high dosages. However,
it has been banned in pig production because people who eat pig products treated with clenbuterol can be poisoned by
the clenbuterol residues. To understand the molecular mechanism for this fat reduction, cDNA microarray, real-time
PCR, two-dimensional electrophoresis and mass spectra were used to study the differential gene expression profiles of
pig adipose tissues treated with/without clenbuterol. The objective of this research is to identify novel genes and
physiological pathways that potentially facilitate clenbuterol induced reduction of adipose accumulation.
Results: Clenbuterol was found to improve the lean meat percentage about 10 percent (P < 0.05). The adipose cells
became smaller and the muscle fibers became thicker with the administration of clenbuterol. The mRNA abundance
levels of 82 genes (ESTs) were found to be statistically differentially expressed based on the Student t-test (P < 0.05) in
the microarray analyses which contained 3358 genes (ESTs). These 82 genes (ESTs) were divided into four groups
according to their Gene Ontology Biological Process descriptions. 16 genes were cellular metabolism related genes
(including five related to lipid metabolism such as apolipoprotein D and apolipoprotein R), 10 were signal transduction
related genes, 45 were expressed sequence tags (ESTs) and 11 others were of various categories. Eleven of the 82 genes
(ESTs) were chosen for real-time PCR analysis, with eight genes showing similar induction magnitude as that seen in the
microarray data. Apolipoprotein R was also found to be up-regulated by the proteomic analysis.
Conclusion: Pig fat accumulation was reduced dramatically with clenbuterol treatment. Histological sections and global
evaluation of gene expression after administration of clenbuterol in pigs identified profound changes in adipose cells. With
clenbuterol stimulation, adipose cell volumes decreased and their gene expression profile changed, which indicate some
metabolism processes have been also altered. Although the biological functions of the differentially expressed genes are
not completely known, higher expressions of these molecules in adipose tissue might contribute to the reduction of fat
accumulation. Among these genes, five lipid metabolism related genes were of special interest for further study, including
apoD and apoR. The apoR expression was increased at both the RNA and protein levels. The apoR may be one of the
critical molecules through which clenbuterol reduces fat accumulation.
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Background
The β2-agonist clenbuterol (0.8–3.2 μg/kg body weight
twice daily) is used as a bronchodilator for the treatment
of asthma in humans and as a bronchodilator as well as a
tocolytic agent in veterinary medicine [1]. In the past dec-
ade, high dosages of clenbuterol (ten to one hundred
times the clinically active dose) have been fed to livestock
to improve feed conversion, reduce body fat and increase
muscle mass [2,3]. However, people who eat the animal
products can be poisoned by the clenbuterol residues [4-
6]. Therefore, the use of clenbuterol for growth promotion
in food-producing animals is not approved within China,
the European community, the United States, and most
other countries [2,7].
Clenbuterol influences cell metabolism by combining
with β2-adrenergic receptors and by increasing the cAMP
concentration in cells. In adipocytes, stimulation of β-
adrenergic receptors (by hormones) increases cyclic AMP
levels and activates protein kinase A (PKA), which stimu-
lates lipolysis by phosphorylating hormone-sensitive
lipase and perilipin [8-11]. However the molecular level
mechanism by which clenbuterol influences adipose
accumulation is still not understood.
Recently, global gene/protein expression analysis tech-
niques using DNA microarray/2-D gel analyses have been
widely used to define the characteristics and specific pat-
terns of gene expressions elicited by various toxicants [12-
14]. In this study, the molecular level mechanism by
which clenbuterol reduces fat accumulation was studied
with cDNA microarray and proteomics techniques to ana-
lyze the fat tissue of Chinese miniature pigs treated with/
without clenbuterol.
Results
Adipose accumulation decreased dramatically by 
clenbuterol administration
HPLC analyses of blood samples showed that the clen-
buterol concentrations in the test pigs fed with clen-
buterol were about 20 ng/ml in the 3 month-old pigs and
about 100 ng/ml in the 4 month-old pigs. Clenbuterol
could not be detected in the control pigs fed without clen-
buterol (Additional file 1 Table S1). The test pigs and con-
trol pigs did not exhibit different weights (Additional file
1 Table S2), but did exhibit different body compositions
(Table 1). The effect of clenbuterol on body composition
became more dramatic with advancing age. In the 3
month-old group, the lean meat percentage was increased
by 2%, the back fat thickness was reduced by ~0.2 cm, and
the loin muscle area was reduced by 4.7 cm2. This differ-
ence was statistically significant (P < 0.05). In the 4
month-old group, the lean meat percentage was increased
by 10.99%, the back fat thickness was reduced by 0.38 cm
and the loin muscle area was reduced by 2.18 cm2. The
changes of the lean meat percentage and the loin muscle
area were strongly statistically significant (P < 0.01) while
the changes of the back fat thickness were statistically sig-
nificant (P < 0.05). These data indicate that clenbuterol
plays a role in pig adipose reduction. The sample quality
was sufficient for further analysis to identify molecules
with changed expression levels and molecules which
impact adipose accumulation.
Muscle fibers became thicker and adipose cells became 
smaller with the administration of clenbuterol
Clenbuterol produces specific protein anabolic effects in
skeletal muscle in addition to lipolysis in adipose tissue of
various vertebrates [15-18]. However, there has not yet
been any research explaining how these two types of tis-
sues are changed by the administration of clenbuterol.
Muscle and adipose histological sections were analyzed to
understand how these two tissue types are changed (Fig-
ure 1A &1B).
Paraffin histological section analyses were done using
samples from the 4 month-old pig's biceps femoris. Four
histological section slides were prepared for each pig, two
transverse muscle fiber slides and two longitudinal mus-
cle fiber slides, for analysis of the cross-sectional area of
the fibers with a TD2000 real-color pathology image anal-
ysis system (Beijing Tiandibainian Scientific Company,
Ltd.). The cross-sectional areas of the muscle fibers of the
test pigs and the control pigs were significantly different
Table 1: Body composition of pigs treated with/without clenbuterol
Age 3 month-old 3 month-old 4 month-old 4 month-old
Clenbuterol dosage* 0 25 0 50
Pig Hog 2 Sow 2 Hog 1 Sow 1 Hog 4 Sow 4 Hog 3 Sow 3
Lean meat percentage of carcass (%) 52.34 52.46 55.09 55.39 41.38 41.52 52.36 52.52
Thickness of back fat (cm) 2.361 2.311 2.132 2.104 3.229 3.171 2.824 2.812
Loin muscle area (cm2) 19.460 19.516 24.086 24.312 23.063 23.103 25.228 25.312
*twice daily with the unit of (mg/kg body weight)
The carcass lean meat percentage, the back fat thickness and the loin muscle area were all changed statistically in both the 3 month-old group and 
the 4 month-old group after clenbuterol treatment (P < .05).BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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with a student t-test P value of 0.0224 (Additional file 1
Table S3). The results show that the administration of
clenbuterol increased the muscle fiber thicknesses in the
pigs.
The 4 month-old pig's back fat tissue (at the fifth lumbar
vertebra level) was also analyzed using paraffin histologi-
cal section. Five random areas on the slides were chosen
for the adipose cell size analyses. The cell sizes were ana-
lyzed by counting all the cells on the slides visible through
the microscope eyepiece at the 10 × 40 magnification
(Additional file 1 Table S4). Numbers of cells in the test
group were strongly statistically more than in the control
group (P < 0.01). Thus, clenbuterol caused a reduction in
adipocyte size.
The clenbuterol thickened the pig muscle fibers and
reduced the sizes of the pig adipocyte cells in the back fat
tissues. Clenbuterol is known to increase muscle mass and
reduce body fat. We suggest that clenbuterol increases the
muscle mass by thickening the muscle fibers and reduces
the body fat by shrinking the adipose cells. The size of the
adipose cells depends on the sizes of the lipid droplets in
the cells. Therefore, the adipose cells become smaller as
the clenbuterol reduces the lipid droplets in the adipose
cells.
cDNA microarray identified 82 genes with changed mRNA 
abundance in adipose tissue with stimulation by 
clenbuterol
Eight microarray slides were used (four for the 3 month-
old group and four for the 4 month-old group) for global
evaluation of the gene expression in the adipose tissue
after administration of clenbuterol. 8335 spots represent-
ing 2770 genes (ESTs) in the 3 month-old group and 8740
spots representing 2862 genes (ESTs) in the 4 month-old
group passed the spots quality filter and were analyzed
with the Student t test. 507 genes in the 3 month-old
1A. Skeleton muscle (biceps femoris) histological section of pigs with/without the administration of clenbuterol Figure 1
1A. Skeleton muscle (biceps femoris) histological section of pigs with/without the administration of clen-
buterol. 1. transverse, test pigs. 2. transverse, control pigs. 3. longitudinal, test pigs. 4. longitudinal, control pigs. Vertical fiber 
sections analyzed with TD2000 real-color pathology image analysis system (Beijing Tiandibainian Scientific Company Ltd.). The 
muscle fibers of pigs become thicker when treated with clenbuterol. 1B. Subcutaneous back fat (at the fifth lumbar ver-
tebra level) histological section of pigs with/without the administration of clenbuterol. 1. amplified10 × 10 of test 
pigs. 2. amplified 10 × 10 of control pigs. 3. amplified 10 × 40 of test pigs. 4. amplified 10 × 40 of control pigs. The sizes of the 
pig adipose cells decreased when treated with clenbuterol. The cell size was analyzed by counting cells on the slide visible 
through the microscope eyepiece.
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group (P < 0.05 in four microarray slides) and 336 genes
in the 4 month-old group (P < 0.05 in four microarray
slides) were differentially expressed (data not shown). The
goal of this study was to identify gene expression profiles
affected by clenbuterol. Therefore, genes that were differ-
entially expressed in both groups (82 genes in total) were
selected for further study as being differentially expressed
in adipose tissue with stimulation by clenbuterol (Fig. 2).
These 82 genes (ESTs) were divided into 4 groups accord-
ing to their Gene Ontology Biological Process descrip-
tions. 16 genes were cellular metabolism related genes
(Table 2), 10 were signal transduction related genes
(Table 3), 45 were expressed sequence tags (ESTs) (Table
4) (no homologous sequences were found in the NCBI
nucleotide database for 17 ESTs, while the other 28 ESTs
hit only some EST sequences without any functional
annotations) and the other 11 genes were of various cate-
gories (Table 5). 45 EST sequences were deposited at
dbEST of NCBI [19].
73% cDNA microarray results confirmed by real-time PCR
Seven differentially expressed genes (positive genes) were
chosen for real-time PCR analysis with the 4 month-old
group samples used to validate the microarray data (Table
6). Clone rpfat_18309 and rpfat_19990 representing pro-
alpha-1 type 3 collagen were not detected by the real-time
PCR. The other five clones, for genes of apoD (apolipo-
protein D), PRKAR1A (cAMP dependent protein kinase
type I regulatory), COL1A2 (pro-alpha-2 chain of type I
procollagen) and COL1A1 (prepro-alpha1(I) collagen),
showed a statistically significant increase in mRNA abun-
dance with administration of clenbuterol (P < 0.05).
The SCD (stearoyl-CoA desaturase) and HSL (hormone-
sensitive lipase) genes are very important in lipid metab-
olism. The mRNA abundance of stearoyl-CoA desaturase
(SCD) decreased in the 3 month-old group and increased
in the 4 month-old group, while HSL was not significantly
differentially expressed by stimulation with clenbuterol in
the microarray analysis. PMP22 (peripheral myelin pro-
tein 22) and PHPT1 (phosphohistidine phosphatase 1)
were also not significantly differentially expressed by
stimulation with clenbuterol in the microarray analysis.
These four genes (negative genes) were not significantly
differentially expressed by the real-time PCR analysis with
8 pig samples (P > 0.05) (Table 7). In total, 11 genes were
analyzed by the real-time PCR. Eight genes showed simi-
lar induction magnitude as that seen in the microarray
data; two could not be detected, and one was inconsistent
with the microarray results. Thus, these results provide
strong biological validation of the results from the micro-
array experiment.
Apolipoprotein R protein highly presented in adipose with 
the administration of clenbuterol
After spot detection, background subtraction and volume
normalization, 600 ± 50 protein spots were detected in
adipose cells using two-dimensional electrophoresis
methods. Two spots found to be only expressed in the test
group were chosen for digestion in-gel for peptide mass
fingerprint (PMF) analysis with a mass spectrograph (Fig.
3A &3B). A Mascot search using the PMF data matched
seven of the peptides with peptides from apolipoprotein
R, with a sequence coverage of 36% and an expectation of
0.00043 [20]. The other differentially expressed protein
did not give any positive results in the database search.
Discussion
To identify the genes responding to clenbuterol treatment
in adipose tissue, a cDNA microarray, real-time PCR and
2-dimensional protein gel analysis were used. 82 genes
were identified as being differentially expressed by the
microarray analysis with student t test (p < 0.05). These
were categorized into to four groups.
Lipid metabolism related genes in group I
16 differentially expressed genes are involved in cellular
metabolism (Table 2). Five of them, including apoD
(apolipoproteinD), apoR (apolipoprotein R), HAD (L-3-
hydroxyacyl-CoA dehydrogenase precursor), PAP type 2A
isoform 1 (phosphatidic acid phosphatase type 2A iso-
form 1) and SCD (stearoyl-CoA desaturase), directly par-
ticipate in lipid metabolism.
82 genes were differentially expressed in the DNA microar- ray analysis in pig fat tissue with clenbuterol administration (P  < .05) in both groups Figure 2
82 genes were differentially expressed in the DNA 
microarray analysis in pig fat tissue with clenbuterol 
administration (P < .05) in both groups. A. The black 
circle indicates the 507 differentially expressed genes in the 3 
month-old group (P < .05 in four microarray slides). B. The 
cross-hatched circle indicates the 336 differentially expressed 
genes in the 4 month-old group (P < .05 in four microarray 
slides). C. The overlapping region indicates the 82 differen-
tially expressed genes in both the 3 month old group and the 
4 month old group that were of interest.BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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Table 2: Group I of differentially expressed genes: Cell metabolism
GenBank Access No. 
(Clone No. on Microarray)
Gene name Annotation* Induction Fold change 
3 month & 4 month
NM_001647 (rpfat_18926) Apolipprotein D (ApoD) Lipid metabolism 1.76 1.67
L06820(rpfat_18262) Apolipprotein R (ApoR) Lipid metabolism 2.58 1.80
XM_854434.1(rpig_3250) Canis familiaris similar to phosphatidic acid 
phosphatase type 2A isoform 1, transcript variant 2
Lipid metabolism 1.27 1.14
NM_006022 (rpigfat_10082) transforming growth factor beta-stimulated 
protein
modulates the frequency, rate 
or extent of DNA-dependent 
transcription
1.25 1.13
NM_007158 (rpfat_18317) NRAS-related gene (D1S155E) 1.25 1.54
NM_014828 (rpfat_16693) KIAA0737 gene product (KIAA0737) 1.28 1.43
NM_003069(rpfat_18518) SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily a, 
member 1 (SMARCA1)
1.23 1.64
NM_000985 (rpfat_19876) ribosomal protein L17 (RPL17), mRNA protein translation 1.47 1.09
LOC484530(rpfat_15686) ribosomal protein S10 protein translation 1.33 1.15
M64620 (rpfat_4179) cathepsin B lysosomal cysteine proteinase 1.14 1.13
DQ673096(rpfat_19771) Eukaryotic translation elongation factor 1 alpha 
(EEF1A)
protein translation 1.70 1.29
X81197(rpfat_13772) archain 1 endoplasmic reticulum to Golgi 
transport
2.15 1.62
AF027652 (rpfat_19670) L-3-hydroxyacyl-CoA dehydrogenase precursor 
(HAD) mRNA,
Lipid metabolism -1.30 1.11
AY487830 (rpfat_17395) Sus scrofa stearoyl-CoA desaturase (SCD) gene, 
exons 1 through 6 and complete cds
Lipid metabolism -1.89 1.03
DQ629164 (rpfat_4193) ribosomal protein L10a protein translation -1.01 1.03
NP_001001636 (rpfat_18915) ribosomal protein L32 Protein translation -1.79 -1.01
*according to description of the Gene Ontology Biological Process Category
*All the genes in the table were differentially expressed according to the student t test in the eight microarray slides (P < .05)
Table 3: Group II of differentially expressed genes: Signal transduction*
GenBank Access No. 
(Clone No. on Microarray)
Gene name Annotation Induction Fold change 3 
month & 4 month
X05942 (rpfat_17661) cAMP dependent protein 
kinase type I regulatory 
(PRKAR1A)
causes the dissociation of the inactive 
holoenzyme
2.0 2.0
Z33879 (rpfat_17754) mRNA encoding G-beta like 
protein (RACK1)
a physiological mediator of agonist-induced 
Ca2+ release
1.29 1.05
NM_204675.1 (rpfat_17793) wingless-type MMTV 
integration site family, member 
3A (WNT3A)
leads to an increase in intracellular calcium and 
activation of protein kinase C (PKC)
1.27 1.09
U57092 (rpfat_19360) RAB30 member of the RAS oncogene family 2.05 2.41
U05291 (rpfat_10974) fibromodulin participate in the assembly of the extracellular 
matrix as it interacts with type I and type II 
collagen fibrils
1.28 1.04
M18981 (rpfat_8258) S100 calcium binding protein 
A6
helps stimulation Ca2+-dependent insulin 
release, prolactin secretion and exocytosis
5.96 1.61
U01160 (rpfat_8561) transmembrane 4 superfamily 
protein (SAS)
growth-related cellular processes 1.09 1.21
AF268463 (rpfat_15672) voltage-dependent anion 
channel 3 (VDAC3)
Calcium signaling pathway -1.26 -1.05
NM_003248 (rpigfat_10263) thrombospondin 4 (THBS4) forms a pentamer and can bind to heparin and 
calcium
-1.04 1.11
BC024040 (rpfat_18349) Homo sapiens CXXC finger 5, 
mRNA
up-regulation of I-kappaB kinase/NF-kappaB 
cascade
-1.41 1.04
*according to description of the Gene Ontology Biological Process Category
*All the genes in the table were differentially expressed according to the student t test in the eight microarray slides (P < .05)BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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Both apoD and apoR were up-regulated by the adminis-
tration of clenbuterol. ApoD is a component of high den-
sity lipoproteins [21]. ApoR is a 23-kDa protein found on
very low-density lipoproteins (VLDL), on chylomicrons,
and in the d > 1.21 g/ml fraction of pig plasma [22]. ApoR
was also found to be up-regulated by proteomic analysis.
Although the physiologic functions of apoD and apoR in
adipose tissue are unknown, they may respond to clen-
buterol stimulation to alter lipid metabolism.
Type 2 PAPs appear to metabolize a wide range of lipid
mediators derived from both glycero- and sphingolipids
[23,24]. SCD is the enzyme responsible for conversion of
saturated fatty acids into monounsaturated fatty acids
Table 4: Group III of differentially expressed genes: Expressed Sequence Tags (ESTs)
GenBank Access No. Clone No. on Microarray Induction Fold change
3 month 4 month
ES605520 rpfat_9071 1.05 1.06
ES605522 rpig_3811 1.63 1.42
ES605503 rpfat_19982 1.41 1.27
ES605504 rpig_3786 1.01 1.10
ES605505 rpfat_11284 1.21 1.21
ES605524 rpfat_17910 1.55 1.05
ES605516 rpfat_15361 1.58 1.25
ES605525 rpfat_15914 1.38 1.13
ES605526 rpfat_16368 1.55 1.12
ES605506 rpfat_18461 1.33 1.07
ES605507 rpfat_11050 1.41 1.17
ES605508 rpigfat_10350 1.84 1.21
ES605509 rpigfat_10251 1.36 1.21
ES605510 rpig_3845 1.06 1.09
ES605511 rpfat_9552 1.05 1.08
ES605528 rpfat_19923 1.24 1.08
ES605530 rpfat_16045 1.36 1.18
ES605532 rpigfat_10253 1.77 1.26
ES605533 rpig_4030 1.07 1.11
ES605535 rpfat_13525 1.49 1.14
ES605536 rpfat_5467 1.79 1.58
ES605537 rpfat_18469 1.18 1.14
ES605538 rpfat_9125 1.34 1.24
ES605539 rpfat_8471 2.32 1.37
ES605540 rpfat_17820 1.39 1.13
ES605513 rpfat_16623 1.54 1.22
ES605541 rpfat_17845 1.21 1.38
ES605543 rpigfat_10285 1.40 1.08
ES605514 rpfat_18411 1.97 1.57
ES605544 rpfat_12523 1.52 1.33
ES605518 rpig_3750 1.60 1.43
ES605515 rpfat_17081 1.57 1.14
ES605519 rpfat_10949 1.08 1.16
ES652311 rpfat_11494 1.05 1.21
ES652312 rpfat_11443 1.09 1.46
ES652313 rpfat_18636 1.83 1.22
ES605523 rpigfat_9891 -1.28 1.04
ES605512 rpfat_19175 -2 1.00
ES605527 rpfat_18872 -1.28 1.03
ES605529 rpfat_10950 -1.59 1.02
ES605534 rpig_3746 -1.03 1.10
ES605531 rpfat_11274 -1.35 1.01
ES605517 rpfat_12459 -1.10 1.08
ES605542 rpfat_15623 -1.51 1.13
ES605521 rpfat_11483 -1.42 -1.06
*All the genes in the table were differentially expressed according to the student t test in the eight microarray slides (P < .05)BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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(MUFA) in mammalian adipocytes [25]. HAD is a mito-
chondrial protein that catalyzes the oxidation of a wide
variety of fatty acids, alcohols, and steroids [26,27].
The identification of these molecules is not sufficient to
draw out the clenbuterol physiological pathway. How-
ever, with the study of the ESTs in Table 4, some new func-
tional genes related to lipid metabolism will be identified.
The mechanism of clenbuterol reducing fat accumulation
will be revealed on the molecular level based on these dif-
ferentially expressed genes.
Other cellular metabolism related genes in group I
Of the other cellular metabolism related genes, EEF1A
(eukaryotic translation elongation factor 1 alpha) is
responsible for the enzymatic delivery of aminoacyl
tRNAs to the ribosome. EEF1A up-regulation indicates
that translation activity in adipose cells is enhanced by
clenbuterol stimulation. Aarchain 1 may be involved in
vesicle structure or trafficking [28] and its up regulation
suggests that transport of cargos from the endoplasmic
reticulum (ER) to the Golgi was enhanced. Cathepsin B is
a lysosomal cysteine proteinase composed of a dimer with
disulfide-linked heavy and light chains. D1S155E (NRAS-
related gene), SMARCA1 (SWI/SNF related, matrix associ-
ated, actin dependent regulator of chromatin, subfamily
a, member 1) and KIAA0737 (KIAA0737 gene product)
modulate the frequency, rate or extent of DNA-dependent
transcription.
Together, these findings indicate that some metabolic
processes, such as DNA transcription, protein translation 
Table 5: Group IV of differentially expressed genes: Various categories*
GenBank Access No. 
(Clone No. on Microarray)
Gene name Annotation Change test/control 3 
month & 4 month
AF246221 (rpfat_12517) transmembrane protein BRI developmental processes 1.27 1.13
AF178980 (rpigfat_9892) D-prohibitin mRNA developmental processes 1.54 1.24
NM_000089 (rpfat_12612) collagen, type I, alpha 2 (COL1A2) developmental processes 2.48 1.53
Z74616 (rpfat_16033) mRNA encoding Pro-alpha-2 chain of type I 
procollagen (COL1A2)
cell structure and mobility 4.20 2.52
AB033007 (rpfat_15395) mRNA for KIAA1181 protein cellular localization 1.29 1.08
X06700 (rpfat_18309) mRNA 3' region for pro-alpha1(III) 
collagen(COL3A1)
cell structure and mobility 3.16 4
Z74615 (rpfat_8523) mRNA for prepro-alpha1(I) collagen 
(COL1A1)
cell structure and mobility 2.86 2.86
X14420 (rpfat_19990) mRNA for pro-alpha-1 type 3 collagen 
(COL3A1)
cell structure and mobility 3.29 3.33
BC093076 (rpigfat_10250) Homo sapiens peptidylprolyl isomerase A 
(cyclophilin A)
protein folding and stabilization 1.28 1.05
NM_006136 (rpfat_18939) capping protein (actin filament) muscle Z-line, 
alpha
cell mobility 2.02 1.61
NM_005915 (rpfat_15643) minichromosome maintenance deficient (mis5, 
S. pombe) 6
cell cycle 1.75 1.62
*according to description of the Gene Ontology Biological Process Category
*All the genes in the table were differentially expressed according to the student t test in the eight microarray slides (P < .05).
Table 6: Real-time PCR validation of microarray positive results
Gene* 
(Clone No. on Microarray)
Hog 3/hog 4 Sow 3/sow 4
Change (test/control) P value Change (test/control) P value
ApoD (rpfat_18926) 12.28 0.013 7.49 0.002
PRKAR1A(rpfat_17661) 6.65 0.014 8.18 0.046
COL1A1 (rpfat_8523) 20.08 0.00008 13.47 0.00001
COL1A2 (rpfat_16033) 2.87 0.0010 3.66 0.0078
COL1A2 (rpfat_17393) 3.00 0.0002 2.29 0.0002
COL3A1(rpfat_18309) Not detected Not detected Not detected Not detected
COL3A1 (rpfat_19990) Not detected Not detected Not detected Not detected
* The full names of each gene are listed in Tables 2-5.
Five of the seven genes were confirmed by real-time PCR.BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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Proteomic study of adipose tissue of pigs with/without the administration of clenbuterol Figure 3
Proteomic study of adipose tissue of pigs with/without the administration of clenbuterol. A. Two-dimensional gel 
analysis of total proteins from adipose tissue treated with/without clenbuterol. (13% SDS-PAGE, silver stain) 600 ± 50 protein 
spots were detected. B. Two differentially expressed protein spots (Amplified from the frame in A).
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Table 7: Real-time PCR validation of microarray negative results
Gene* (Clone No. 
on Microarray)
Hog 1/hog 2 Sow 1/sow 2 Hog 3/hog 4 Sow 3/sow 4
Change 
(test/control)
P value Change 
(test/control)
P value Change 
(test/control)
P value Change 
(test/control)
P value
SCD (rpfat_16685) 1.56 0.1680 0.77 0.2119 1.49 0.0822 1.23 0.9943
HSL (rpfat_11096) 1.29 0.0679 1.11 0.2989 1.29 0.3462 1.06 0.5294
PMP22a 
(rpfat_18575)
1.15 0.6198 1.16 0.3178 1.24 0.6900 1.46 0.1175
PHPT1b 
(rpfat_15312)
0.75 0.1218 0.95 0.5811 1.24 0.4694 1.46 0.4869
* The full names of each gene are listed in Tables 2-5.
a : PMP22: peripheral myelin protein 22
b :PHPT1: Phosphohistidine phosphatase 1
Three genes (HSL, PMP22 and PHPT1) were confirmed by real-time PCR.BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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and protein translocation, were enhanced in the adipose
cells by clenbuterol stimulation.
cAMP signaling pathway related genes in group II
The beta-androgenic receptor (β-AR) signal pathway has
been well described previously [11]. Clenbuterol as a
beta-agonist works by binding with β-AR which then
transmits signals into the cell along the G protein-medi-
ated cAMP signal pathway [29]. However, the molecular
level mechanisms by which clenbuterol affects adipose
accumulation are still unknown. To examine the expres-
sion level of genes related to cAMP or G-protein, a total of
11 genes were found directly related to cAMP or G-protein
in the microarray gene list. Only two of the eleven were
found to be up-regulated, the cAMP dependent protein
kinase type I regulatory gene (PRKAR1A) and RAB30
(Table 3). Up-regulation of PRKAR1A was confirmed by
the real-time PCR. No reports have been found concern-
ing functions of PRKAR1A and RBA30 in adipose cells.
Other signal transduction related genes in group II
Another seven signal transduction genes were found to be
differentially expressed (Table 3). Five genes (RACK1,
WNT3A, VDAC3, S100A6, THBS4) encoding signal trans-
duction molecules are calcium related. This indicates that
clenbuterol may have an impact on calcium signaling
pathways in cells. Both RACK1 and WNT3A activate pro-
tein kinase C, while protein kinase A has previously been
reported as the target of clenbuterol. All this data suggests
that clenbuterol's effects on adipose cell may be more
complex than previously suggested.
Fibromodulin participates in the assembly of the extracel-
lular matrix as it interacts with type I and type II collagen
fibrils [30]. Several collagen genes were also found to be
up-regulated (Table 5). This indicates that clenbuterol
may have an effect on cell collagen synthesis which may
alter the cell matrix composition. It is difficult to deter-
mine whether this has any relationship to trigalloyl glyc-
erol accumulation.
ESTs sequence in group IV
45 differentially expressed ESTs are listed in Table 4. Spe-
cific conclusions can not be derived from these ESTs
results at this time. Some key genes for lipid metabolism,
which are unknown at this time, may be found from this
list in the future.
Clenbuterol stimulates genes up-regulated
Only three genes were found to be down-regulated in the
82 differentially expressed genes. To further investigate
whether some genes were down-regulated by the admin-
istration of clenbuterol, PHPT1 (phosphohistidine phos-
phatase 1) and PMP22 (peripheral myelin protein 22)
were analyzed by real-time PCR (Table 7). These two
genes were down-regulated in the 3 month-old group (p
= 0.03), but they were not statistically differentially
expressed in the 4 month-old group (p = 0.09) by the
microarray analysis. The PCR results showed that the
mRNA expression of these two genes were not changed
significantly (P > 0.05) which confirms the unusual
microarray result that very few genes were suppressed.
This data suggests that clenbuterol stimulates gene up-reg-
ulation in adipose cells.
Conclusion
Pig fat accumulation was reduced dramatically with clen-
buterol treatment. Histological sections and global evalu-
ation of gene expression after administration of
clenbuterol in pigs identified profound changes in adi-
pose cells. With clenbuterol stimulation, adipose cell vol-
umes decreased and their gene expression profile
changed, which indicate some metabolism processes have
been also altered. Although the biological functions of the
differentially expressed genes are not completely known,
higher expressions of these molecules in adipose tissue
might contribute to the reduction of fat accumulation.
Among these genes, five lipid metabolism related genes
were of special interest for further study, including apoD
and apoR. The apoR expression was increased at both the
RNA and protein levels. The apoR may be one of the crit-
ical molecules through which clenbuterol reduces fat
accumulation.
Methods
Animal sampling and clenbuterol treatment
Eight Chinese miniature pigs were used in the experi-
ments. Four hogs and four sows, all 4 weeks old, were
housed in the Nutrition and Metabolism Laboratory at
the China Agriculture University. They were raised under
exactly the same conditions and were fed the same diets
until 8 weeks (average body weight 17 kg). They were ran-
domly divided into 4 groups with each group having two
pigs with the same gender and the same parents. For the
following 4 weeks, one pig in each group was fed 25 mg/
kg clenbuterol twice daily in their diets as the test pig,
while the other was fed the same diet without clenbuterol
as the control. Then one group of hogs and one group of
sows were slaughtered for analysis. These two groups are
referred to as the 3 month-old pigs. The other two groups
were fed with/without 50 mg/kg clenbuterol twice daily in
their diets for another 4 weeks and slaughtered for analy-
sis. These two groups are referred to as the 4 month-old
pigs. Approximately 1 g biopsies of different tissues,
including the back fat adipose tissues (at the fifth lumbar
vertebra level), skeleton muscle (biceps femoris and sural
muscle), liver, heart, kidney, spleen and lung, were taken
from each pig. Samples were washed in sterile water, snap
frozen in liquid nitrogen and stored at -80°C.BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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Histology
Tissue samples were fixed in 4% formaldehyde in PBS,
embedded in paraffin, and sectioned (5 μm sections).
After deparaffinization and rehydration, the sections were
washed three times with PBS and stained with H&E.
RNA preparation, RNA labeling and DNA microarray 
hybridization
Total RNA of the adipose tissue was extracted with TRI-
ZOL reagent (Invitrogen, Gaithersburg, MD, USA) and
further purified with an RNeasy mini kit (Qiagen, Valen-
cia, CA, USA) according to the manufacturers' instruc-
tions.
The porcine cDNA microarray was produced at the China
Agricultural University. A total of 11520 spots represent-
ing 3358 genes (ESTs) were included on the microarray
slide. 3358 genes (ESTs) were cloned from the porcine
adipose cDNA library and printed in triplicate on each
slide. (More details on the specific genes and probe
sequences are given by Guo et al. [31]).
A cDNA microarray hybridization analysis was performed
with Pronto!™ Universal Microarray Kits (Corning, MA,
USA) according to the manufacturers instructions. Briefly,
reverse transcription was done with 10 μg total RNA as the
template to synthesize cDNA incorporating the fluores-
cence dyes Cy3-dCTP or Cy5-dCTP. Probes were purified
on a Qiagen spin column (Qiagen, Valencia, CA, USA).
Dye-labelled cDNA was mixed together with dry dye-
labeled cDNA for hybridization (see Pronto Universal
hybridization kit Quick Reference Guide).
To avoid dye bias, the experiments were performed in
duplicate by dye swap with Cy5-dCTP first used with the
test pig and Cy3-dCTP used with the control pig and then
Cy3-dCTP used with the test pig and Cy5-dCTP used with
the control pig.
Eight cDNA microarray slides were hybridized for the
eight pigs.
DNA microarray Imaging and data analysis
Arrays were scanned with a ScanArray Express scanner
(Parckard Bioscience, Kanata, OT, USA) with the obtained
images analyzed with GenePix Pro 4.0 (Axon Instruments,
Foster City, CA) and Acuity 4.0 (Axon Instruments, Foster
City, CA). The resulting microarray data was then normal-
ized using the space and intensity-dependent normaliza-
tion in the LOWESS program [32]. Each gene was
represented in triplicate on each slide. The intensity
(median) of each spot was analyzed using the student t-
test to identify the differentially expressed genes (P <
0.05). Low quality spots were filtered out before the stu-
dent t-test analysis. Low quality spots refer to stained spots
with bad images or spots with intensities (median) lower
than 200 (too weak) or greater than 60000 (saturated).
Differentially expressed genes were defined as genes with
P values less than 0.05 in the eight microarray slides. The
mean ratios of the differentially expressed genes (ESTs)
were calculated as the "ratio of the median" of three spots
to indicate the trends in the changes of the mRNA abun-
dance.
The microarray data from this research has been deposited
in the NCBI Gene Expression Omnibus data repository
under accession numbers GSE8093 [33].
Quantitative Real-Time PCR
Fluorescent real-time PCR was used to confirm the tran-
scriptional differences observed in the microarray results,
The real-time PCR was done on an ABI Prism 9700
Sequence Detection system (Applied Biosystems, Foster,
CA, USA) using SYBRgreen technology as described by Li
et al. [34]. The PCR primer sequences used for the real-
time PCR are shown in Table 8. The PCR reaction volume
was 20 μl with the following program:
50°C 2 min (activate the uracil-N-glycosylase enzyme);
95°C 10 min (initial denaturation of the cDNA) ;
40 cycles (1 sec at various elevated temperatures for data
acquisition): 95°C 20 sec, annealing (according to the
specifications for each primer) 20 sec, 72°C 20 sec;
72°C 10 min (reformation of fully duplexed DNA);
The dissolve curve analysis used heating from 65 to 95°C,
with increases of 0.2°C per step with the system held 1 sec
at each temperature.
All samples were measured in triplicate. Expression was
quantified by the relative standard curve method. A stand-
ard graph of the cycle threshold (CT) values was obtained
from serial dilutions (10-1–10-8 copies/well) of Glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH, a house-
keeping gene) cDNA. The quantification was normalized
to an endogenous RNA control of the GAPDH or beta2-
microglobulin (B2M). An independent sample t-test was
used to analyze differences in mRNA expression with/
without administration of clenbuterol. Differences were
considered to be statistically significant at P < 0.05. Reac-
tions for which the housekeeping gene's CT values were
less than 15 or more than 25 were discarded in the calcu-
lations because the start cDNA concentration was not
appropriate or the cDNA quality was not good enough.BMC Genomics 2007, 8:433 http://www.biomedcentral.com/1471-2164/8/433
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Proteome analysis
Protein extraction from adipose cells, two-dimensional
electrophoresis and in-gel digestion were conducted as
described by Lee et al. [35]. After in-gel digestion, samples
were dissolved in 4 ml 0.5% aqueous trifluoroacetic acid
for mass spectrometric analysis on a Bruker REFLEX III
MALDI-TOF-MS (Bruker-Franzen, Bremen, Germany) in
positive ion mode at an accelerating voltage of 20 kV with
an a-cyano-4-hydroxy cinnamic acid matrix. The resulting
peptide mass fingerprint (PMF) was then used in a search
of the SWISS-PROT and NCBInr databases using the Mas-
cot search engine [20] with a tolerance of ± 0.2 D and one
missed cleavage site.
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